Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Qinghai Gelatin to Sell TCM Subsidiary to Chongqing Lummy Pharma

publication date: Dec 9, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Qinghai Gelatin has reached a framework agreement to sell its drug making subsidiary, Sichuan Hezheng Pharmaceutical, to Chongqing Lummy Pharmaceutical for 90 million RMB ($13.5 million). Hezheng Pharma produces TCM products in the form of pills, granules, capsules, tablets, and non-food health products.  More details....

Stock Symbols: (SHEX: 000606) (SHEX: 300006)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events


BioPacific Conference 2012
June 2, 2012
California, USA

  China Forum 2012
  November 11, 2012
Hamburg, Germany

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners